Recurrence of macular edema associated with branch retinal vein occlusion after intravitreal bevacizumab

被引:24
作者
Hanada, Narihisa [1 ]
Iijima, Hiroyuki [1 ]
Sakurada, Yoichi [1 ]
Imasawa, Mitsuhiro [1 ]
机构
[1] Univ Yamanashi, Fac Med, Dept Ophthalmol, Chuo Ku, Yamanashi 4093898, Japan
关键词
Branch retinal vein occlusion; Intravitreal bevacizumab; Recurrence; Retreatment; Optical coherence tomography; TRIAMCINOLONE ACETONIDE; SECONDARY; THERAPY; INJECTION; AVASTIN;
D O I
10.1007/s10384-011-0113-4
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
To study the recurrence of macular edema and the probability of retreatment with intravitreal bevacizumab (IVB) of eyes with macular edema associated with branch retinal vein occlusion (BRVO). In this retrospective study of an interventional case series, the temporal profile of visual acuity and retinal thickness after individual IVB, either initial or repeated, was investigated for eyes with acute BRVO associated with symptomatic macular edema. In a total of 95 IVB treatment sessions conducted on 37 eyes of 37 patients, 25 injections were completed with a follow-up period of 6 months or longer without any additional treatments. Fifty-eight IVB injections were followed by retreatment with IVB after an average interval of 119 days (range 42-308 days) since the preceding IVB injection. The remaining 12 injections were followed either by an insufficient follow-up period of less than 6 months or by laser treatment. Although retreatment with IVB because of recurrence of macular edema is common, in this study, the probability of retreatment with IVB was approximately 70% after each individual IVB injection, indicating that 4 injections is maximum for three-quarters of eyes with BRVO macular edema.
引用
收藏
页码:165 / 174
页数:10
相关论文
共 26 条
  • [1] Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion
    Ach, Thomas
    Hoeh, Alexandra E.
    Schaal, Karen B.
    Scheuerle, Alexander F.
    Dithmar, Stefan
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (02) : 155 - 159
  • [2] The effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusion
    Ahmadi, Arnir Ali
    Chuo, Jean Y.
    Banashkevich, Alexander
    Ma, Patrick E.
    Maberley, David A. L.
    [J]. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2009, 44 (02): : 154 - 159
  • [3] [Anonymous], 1984, AM J OPHTHALMOL, V98, P271
  • [4] The treatment of branch retinal vein occlusion with bevacizumab
    Badala, Federico
    [J]. CURRENT OPINION IN OPHTHALMOLOGY, 2008, 19 (03) : 234 - 238
  • [5] Intravitreal triamcinolone acetonide versus bevacizumab therapy for macular edema associated with branch retinal vein occlusion
    Byun, Yeo Jue
    Roh, Mi In
    Lee, Sung Chul
    Koh, Hyoung Jun
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (07) : 963 - 971
  • [6] Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion
    Cheng, K-C
    Wu, W-C
    Chen, K-J
    [J]. EYE, 2009, 23 (11) : 2024 - 2032
  • [7] SAFETY AND EFFICACY OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR THE MANAGEMENT OF BRANCH AND HEMIRETINAL VEIN OCCLUSION
    Gregori, Ninel Z.
    Rattan, Ginger Henson
    Rosenfeld, Philip J.
    Puliafito, Carmen A.
    Feuer, William
    Flynn, Harry W., Jr.
    Berrocal, Audina M.
    Al-Attar, Luma
    Dubovy, Sander
    Smiddy, William E.
    Schwartz, Stephen G.
    Lee, Wen-Hsiang
    Murray, Timothy G.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (07): : 913 - 925
  • [8] Comparison of Bevacizumab and Triamcinolone for Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion in a Pair-Matched Analysis
    Guthoff, Rainer
    Meigen, Thomas
    Hennemann, Kathrin
    Schrader, Wolfgang
    [J]. OPHTHALMOLOGICA, 2010, 224 (05) : 319 - 324
  • [9] Topography of diabetic macular edema with optical coherence tomography
    Hee, MR
    Puliafito, CA
    Duker, JS
    Reichel, E
    Coker, JG
    Wilkins, JR
    Schuman, JS
    Swanson, EA
    Fujimoto, JG
    [J]. OPHTHALMOLOGY, 1998, 105 (02) : 360 - 370
  • [10] Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion
    Hoeh, Alexandra E.
    Ach, Thomas
    Schaal, Karen B.
    Scheuerle, Alexander F.
    Dithmar, Stefan
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 247 (12) : 1635 - 1641